VALNEVA (EPA:VLA) | Finanzwire

PRESS RELEASE

published on 04/09/2025 at 07:00, 1 year 6 months ago

Valneva and LimmaTech Announce First Vaccination in Phase 2 Infant Study of Tetravalent Shigella Vaccine Candidate S4V2
Valneva and LimmaTech announce first vaccination in Phase 2 infant study of tetravalent Shigella vaccine candidate S4V2. Study aims to combat shigellosis, a deadly diarrheal disease

Valneva Phase 2 Study Shigella Vaccine Shigellosis LimmaTech
PRESS RELEASE

published on 03/20/2025 at 07:00, 1 year 7 months ago

Valneva Reports Full Year 2024 Results and Provides Business Updates and Outlook
Valneva SE reports solid full year 2024 results exceeding growth targets. Financial outlook for 2025 includes strong revenue growth and strategic investments. Key milestones and financial information discussed

Financial Results Valneva 2025 Outlook Vaccine Company Clinical Progress
BRIEF

published on 02/05/2025 at 07:05, 1 year 8 months ago

Valneva Achieves UK Approval for World's First Chikungunya Vaccine

Public Health Valneva Chikungunya Vaccine UK Approval Travel Safety
PRESS RELEASE

published on 02/05/2025 at 07:00, 1 year 8 months ago

Valneva Receives Marketing Authorization in the UK for the World’s First Chikungunya Vaccine, IXCHIQ®
Valneva receives marketing authorization in the UK for the world's first chikungunya vaccine, IXCHIQ®. Single-dose vaccine for individuals 18+ provides rapid and strong immune response

UK Valneva MHRA Chikungunya Vaccine IXCHIQ®
BRIEF

published on 12/05/2024 at 07:35, 1 year 10 months ago

Valneva Reports Share and Voting Rights as of November 30, 2024

Euronext Paris Share Capital Voting Rights Valneva Double Voting
PRESS RELEASE

published on 12/05/2024 at 07:30, 1 year 10 months ago

VALNEVA - Declaration of shares and voting rights: November 30, 2024
VALNEVA declares transfer of 1,000 shares into bearer form with double voting rights on November 26, 2024. Total voting rights: 178,371,727

Euronext Paris Voting Rights Shares Stock Market Valneva
BRIEF

published on 12/04/2024 at 10:02, 1 year 10 months ago

Polar Capital reduces its stake in VALNEVA SE

Voting Rights Actions Valneva SE Threshold Crossing Polar Capital
BRIEF

published on 12/04/2024 at 07:05, 1 year 10 months ago

Valneva Publishes Findings on Chikungunya Impact in British Medical Journal

Climate Change Chikungunya Health Impact Economic Burden Global Study
PRESS RELEASE

published on 12/04/2024 at 07:00, 1 year 10 months ago

Valneva Announces Peer-Reviewed Publication on the Global Health and Economic Burden of Chikungunya in The British Medical Journal
Valneva SE announces the publication of an article on the global health and economic burden of chikungunya in The British Medical Journal, revealing higher disease burden and substantial costs

Valneva SE Global Health Chikungunya Economic Burden British Medical Journal
BRIEF

published on 11/26/2024 at 17:50, 1 year 11 months ago

Valneva Seeks FDA Approval for Chikungunya Vaccine Expansion

Valneva FDA Application Chikungunya Vaccine Adolescents Antibody Persistence

Published on 10/30/2026 at 23:35, 2 days 10 hours ago

Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 2 days 10 hours ago

Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 20:47, 2 days 13 hours ago

CoTec Holdings Corp. Comments on Share Trading
Published on 10/30/2026 at 19:00, 2 days 15 hours ago

Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 2 days 18 hours ago

Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split

View all ACCESSWIRE

Published on 11/02/2026 at 09:30, 52 minutes ago

Europe's first bond for New Space investing is open for subscription from today: European Space Bond, 8% p.a. fixed interest.
Published on 11/02/2026 at 09:20, 1 hour 2 minutes ago

Original-Research: SFC Energy AG (von First Berlin Equity Research GmbH): Buy
Published on 11/02/2026 at 09:00, 1 hour 22 minutes ago

Original-Research: Gallmetzer HealthCare SpA (von NuWays AG): BUY
Published on 11/02/2026 at 09:00, 1 hour 22 minutes ago

Original-Research: bet-at-home.com AG (von NuWays AG): BUY
Published on 11/02/2026 at 09:00, 1 hour 22 minutes ago

Mutares has sold SRT Group and its subsidiaries to Quiver

View all EQS

Published on 10/30/2026 at 23:00, 2 days 11 hours ago

BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 20:42, 2 days 13 hours ago

TINC and PMV invest in Storm Group (B)
Published on 10/30/2026 at 18:00, 2 days 16 hours ago

2026 half-year earnings & third quarter revenue
Published on 10/30/2026 at 12:00, 2 days 22 hours ago

Capital increase through exercise of subscription rights
Published on 10/30/2026 at 08:45, 3 days 1 hour ago

Share buyback

View all LES ECHOS COMFI WIRE

News